Outcomes of Transscleral Diode LaserCyclophotocoagulation in End-Stage Glaucoma Patients
Yıl: 2020 Cilt: 29 Sayı: 2 Sayfa Aralığı: 113 - 117 Metin Dili: İngilizce DOI: 10.37844/glauc.cat.2020.15.21 İndeks Tarihi: 05-05-2021
Outcomes of Transscleral Diode LaserCyclophotocoagulation in End-Stage Glaucoma Patients
Öz: Purpose: The aim of the study was to determine outcomes of diode laser transscleral cyclophotocoagulation (DLTCPC) in end-stage glaucoma (ESG). Materials and Methods: We retrospectively reviewed fi le recordings of 23 eyes of 23 patients with ESG (9 female, 14 male). Visual acuity, intraocular pressure (IOP) levels, number of medical agents needed (MAN), pain sensation (PS) score and complications were evaluated before and after the procedure. Measurements obtained before and on week 1and at months 1, 3 and 6 after the procedure were analyzed statistically.Results: There was a statistically signifi cant decrease in IOP values at all time points when compared to preoperative values. While the mean MAN was 3.91 before the laser treatment, it was 3.22 (p=0.004) at the fi nal control visit. PS was decreased from 2.67 before laser treatment to 0.89 (p=0.004) at fi nal control visit. There was no complication related to DLTCPC, including hypotonia.Conclusion: In the treatment of ESG; DLTCPC treatment, which provides a signifi cant decrease in IOP, can decrease MAN, reduce pain complaints and has low complication rates, is an effective and reliable treatment method.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Bibliyografik
- 1- Gillies WE, Brooks AM, Strang NT. Management and prognosis of end-stage glaucoma. Clin Exp Ophthalmol 2000;28:405-8.
- 2- Aggarwal SP, Hendels S. Risk of sudden visual loss following trabeculectomy in advanced primary open-angle glaucoma. Br J Ophthalmol 1986;70:97-9.
- 3- Awai M, Koga T, Inatani M, et al. Stability of the central visual fi eld after modern trabeculectomy techniques in eyes with advanced glaucoma. Jpn J Ophthalmol 2007; 51:116-20.
- 4- Law SK, Nguyen AM, Coleman AL, et al. Severe loss of central vision in patients with advanced glaucoma undergoing trabeculectomy. Arch Ophthalmol 2007;125:1044-50.
- 5- Şimşek T. Dirençli Glokomda Siklodestrüktif Cerrahi. GloKat 2017;12:239-45.
- 6- Melzack R, Katz J, McMahon SB, et al. Pain assesement in adult patients. Wall and Melzack’s Textbook of Pain. London Elsevier;2006;5th ed;291-304.
- 7- Benson MT, Nelson ME. Cyclocryotherapy: a review of cases over a 10-year period. Br J Ophthalmol 1990; 74:103-5.
- 8- Schuman JS, Bellows AR, Shingleton BJ, et al. Contact transscleral Nd:YAG laser cyclophotocoagulation. Ophthalmology 1992;99:1089-95.
- 9- Iliev ME, Gerber S. Long-term outcome of trans-scleral diode laser cyclophotocoagulation in refractory glaucoma. Br J Ophthalmol 2007;91:1631-5.
- 10- Subrata M, Ritu G, Jatin A. Diode laser cyclophotocoagulation. J Curr Glaucoma Pract 2009;3:47-59.
- 11- Van der Zypen E, England C, Fankhauser F, et al. The effect of transscleral laser cyclophotocoagulation on rabbit ciliary body vascularization. Graefes Arch Clin Exp Ophthalmol 1989;227:172-9.
- 12- Morrison J, Pollack I. Cyclodestruction. In: Morisson J, Pollack I, editors. Glaucoma: Science and practice. New York:Thieme;2003;448-55.
- 13- Abdull MM, Broadway DC, Evans J, et al. Safety and effectiveness of primary transscleral diode laser cyclophotoablation for glaucoma in Nigeria. Clin Exp Ophthalmol. 2018 doi: 10.1111/ceo.13328, Epub ahead of print.
- 14- Frezzotti P, Mittica V, Martone G, et al. Longterm followup of diode laser transscleral cyclophotocoagulation in the treatment of refractory glaucoma. Acta Ophthalmol 2010;88:150-5.
- 15- Ramli N, Htoon HM, Ho CL, et al. Risk factors for hypotony after transscleral diode cyclophotocoagulation. J Glaucoma 2012;21:169-73.
- 16- Schlote T, Derse M, Rassmann K, et al. Effi cacy and safety of contact transscleral diode laser cyclophotocoagulation for advanced glaucoma. J Glaucoma 2001;10:294-301.
- 17- Mistelberger A, Liebmann J, Tschiderer H, et al. Diode laser transscleral cyclophotocoagulation for refractory glaucoma. J Glaucoma. 2001;10:288-93.
- 18- Bitirgen G, Okka M, Bozkurt B, et al. Transscleral Diode Laser Cyclophotocoagulation in Refractory Glaucoma. Turk J Ophthalmol 2012;42:434-7.
- 19- Öztürk T, Arıkan G, Ünlü B, et al. Görme Keskinliği İyi Olan Glokom Hastalarında Transskleral Diod Laser Siklofotokoagülasyon. Glo-Kat 2017;12:37-41.
- 20- Souissi S, Baudouin C, Labbé A, et al. Micropulse transscleral cyclophotocoagulation using a standard protocol in patients with refractory glaucoma naive of cyclodestruction. Eur J Ophthalmol 2019;doi: 10.1177/1120672119877586. Epub ahead of print.
| APA | DURSUN O, YILMAZ A, DINC E, TEMEL G (2020). Outcomes of Transscleral Diode LaserCyclophotocoagulation in End-Stage Glaucoma Patients. , 113 - 117. 10.37844/glauc.cat.2020.15.21 |
| Chicago | DURSUN Ozer,YILMAZ Ayca,DINC Erdem,TEMEL Gulhan Outcomes of Transscleral Diode LaserCyclophotocoagulation in End-Stage Glaucoma Patients. (2020): 113 - 117. 10.37844/glauc.cat.2020.15.21 |
| MLA | DURSUN Ozer,YILMAZ Ayca,DINC Erdem,TEMEL Gulhan Outcomes of Transscleral Diode LaserCyclophotocoagulation in End-Stage Glaucoma Patients. , 2020, ss.113 - 117. 10.37844/glauc.cat.2020.15.21 |
| AMA | DURSUN O,YILMAZ A,DINC E,TEMEL G Outcomes of Transscleral Diode LaserCyclophotocoagulation in End-Stage Glaucoma Patients. . 2020; 113 - 117. 10.37844/glauc.cat.2020.15.21 |
| Vancouver | DURSUN O,YILMAZ A,DINC E,TEMEL G Outcomes of Transscleral Diode LaserCyclophotocoagulation in End-Stage Glaucoma Patients. . 2020; 113 - 117. 10.37844/glauc.cat.2020.15.21 |
| IEEE | DURSUN O,YILMAZ A,DINC E,TEMEL G "Outcomes of Transscleral Diode LaserCyclophotocoagulation in End-Stage Glaucoma Patients." , ss.113 - 117, 2020. 10.37844/glauc.cat.2020.15.21 |
| ISNAD | DURSUN, Ozer vd. "Outcomes of Transscleral Diode LaserCyclophotocoagulation in End-Stage Glaucoma Patients". (2020), 113-117. https://doi.org/10.37844/glauc.cat.2020.15.21 |
| APA | DURSUN O, YILMAZ A, DINC E, TEMEL G (2020). Outcomes of Transscleral Diode LaserCyclophotocoagulation in End-Stage Glaucoma Patients. Glokom Katarakt, 29(2), 113 - 117. 10.37844/glauc.cat.2020.15.21 |
| Chicago | DURSUN Ozer,YILMAZ Ayca,DINC Erdem,TEMEL Gulhan Outcomes of Transscleral Diode LaserCyclophotocoagulation in End-Stage Glaucoma Patients. Glokom Katarakt 29, no.2 (2020): 113 - 117. 10.37844/glauc.cat.2020.15.21 |
| MLA | DURSUN Ozer,YILMAZ Ayca,DINC Erdem,TEMEL Gulhan Outcomes of Transscleral Diode LaserCyclophotocoagulation in End-Stage Glaucoma Patients. Glokom Katarakt, vol.29, no.2, 2020, ss.113 - 117. 10.37844/glauc.cat.2020.15.21 |
| AMA | DURSUN O,YILMAZ A,DINC E,TEMEL G Outcomes of Transscleral Diode LaserCyclophotocoagulation in End-Stage Glaucoma Patients. Glokom Katarakt. 2020; 29(2): 113 - 117. 10.37844/glauc.cat.2020.15.21 |
| Vancouver | DURSUN O,YILMAZ A,DINC E,TEMEL G Outcomes of Transscleral Diode LaserCyclophotocoagulation in End-Stage Glaucoma Patients. Glokom Katarakt. 2020; 29(2): 113 - 117. 10.37844/glauc.cat.2020.15.21 |
| IEEE | DURSUN O,YILMAZ A,DINC E,TEMEL G "Outcomes of Transscleral Diode LaserCyclophotocoagulation in End-Stage Glaucoma Patients." Glokom Katarakt, 29, ss.113 - 117, 2020. 10.37844/glauc.cat.2020.15.21 |
| ISNAD | DURSUN, Ozer vd. "Outcomes of Transscleral Diode LaserCyclophotocoagulation in End-Stage Glaucoma Patients". Glokom Katarakt 29/2 (2020), 113-117. https://doi.org/10.37844/glauc.cat.2020.15.21 |
